Close
Nordic 9Nordic 9

Humboldt (investor - Venture Capital)

United States humboldtfund.com
See something wrong or missing? Let us know
Offices:New York

Humboldt Fund is a venture capital fund that supports innovative, early-stage companies by investing in the biotech revolution.

Average round investment:47M USD
Average number per year:1.0
Distribution: 2022 (1)2021 (1)
Portfolio companies: Switzerland Haya TherapeuticsNetherlands Meatable
Mostly invests in: Switzerland Switzerland (1) Biotech (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Humboldt

Name Criteria
United States Acorn Bioventures
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
Netherlands Aqua-Spark
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
United States KB Partners
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
Sweden Recipharm Venture Fund
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
Switzerland Yann Sommer
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
United States Mayo Clinic
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
United States Rick Klausner
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
France BOLD - Business Opportunities for L'Oréal Development
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
Greece Olympic Investments
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Food Industry, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
Switzerland LimmaTech Biologics AG
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
Top